10-K · February 26, 2026
PROCEPT reported full-year revenue of $308.1 million for the year ended December 31, 2025, up from $224.5 million in 2024, driven by system placements and disposables, but continued to incur losses (net loss $95.6…
Earnings analysis · 10-Q
PRCT earnings analysis
Filed April 30, 2026 · Our reading of the company's report
The latest report
PROCEPT BioRobotics recognized significant growth in Q1 2026, reporting revenues of $83.13 million, a 20% increase from $69.16 million in Q1 2025. Despite the growth in revenue, the company netted a loss of $31.64…
Read full summary
PROCEPT BioRobotics recognized significant growth in Q1 2026, reporting revenues of $83.13 million, a 20% increase from $69.16 million in Q1 2025. Despite the growth in revenue, the company netted a loss of $31.64 million compared to a loss of $24.74 million in the previous year, primarily due to increased operating expenses for research and development as well as sales and administrative costs.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.56
- Gross margin
- 65%
What stood out
-
Significant Revenue Increase
Revenue rose by 20% to $83.1 million compared to $69.2 million in Q1 2025.
-
Improved Gross Margin
Gross margin increased to 65% in Q1 2026 from 64% in Q1 2025.
-
Increased System Sales
System sales and leases grew by 21% to $27.24 million.
-
Higher Consumables Revenue
Handpieces and consumables revenue increased by 16% to $49.39 million.
-
Operational Growth
The total number of installed robotic systems reached 971, with a focus on increasing utilization and sales in the U.S.
-
Strong Cash Position
Cash and cash equivalents totaled $245.6 million as of March 31, 2026.
What to watch
-
Rising Operating Loss
Net loss increased by 28% to $31.64 million from $24.74 million in Q1 2025.
-
Increased Operating Expenses
Total operating expenses rose 21% to $86.55 million, driven by higher R&D and SG&A costs.
-
Liquidity Concerns
Despite a strong cash position, increased operational expenses may pressure future liquidity.
Management's outlook
Management continues to anticipate annual revenue growth of 27% to 33% for 2026 compared to 2025.
Earlier filings 4
10-K · February 27, 2025
PROCEPT reported a strong revenue growth of 64.8% year-over-year, achieving $224.5 million in 2024, up from $136.2 million in 2023. However, the company is still incurring significant losses with a net loss of $91.4…
10-Q · October 28, 2024
PROCEPT reported Q3 revenue of $58.37M (up from $35.10M in Q3 2023 and up vs Q2 2024 ~$53.35M), driving gross profit of $36.91M and a gross margin of 63.2%. Operating loss narrowed to $(22.43)M and diluted loss per…
10-Q · August 2, 2024
PROCEPT reported strong top-line growth in Q2 with revenue of $53,353,000 (up from $33,104,000 in Q2 2023) and gross profit of $31,482,000, driving a gross margin of 59.0%. Despite revenue and margin improvement,…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.